Φορτώνει......
Recent advances in T-cell engineering for use in immunotherapy
Adoptive T-cell therapies have shown exceptional promise in the treatment of cancer, especially B-cell malignancies. Two distinct strategies have been used to redirect the activity of ex vivo engineered T cells. In one case, the well-known ability of the T-cell receptor (TCR) to recognize a specific...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | F1000Res |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
F1000Research
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5031132/ https://ncbi.nlm.nih.gov/pubmed/27703664 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.9073.1 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|